BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 8162648)

  • 21. The role of cytokines in arthritic diseases: in vitro and in vivo measurements of cartilage degradation.
    Dingle JT; Page Thomas DP; Hazleman B
    Int J Tissue React; 1987; 9(4):349-54. PubMed ID: 3497901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and characterization of a lubricin mimic (mLub) to reduce friction and adhesion on the articular cartilage surface.
    Lawrence A; Xu X; Bible MD; Calve S; Neu CP; Panitch A
    Biomaterials; 2015 Dec; 73():42-50. PubMed ID: 26398308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diminished cartilage-lubricating ability of human osteoarthritic synovial fluid deficient in proteoglycan 4: Restoration through proteoglycan 4 supplementation.
    Ludwig TE; McAllister JR; Lun V; Wiley JP; Schmidt TA
    Arthritis Rheum; 2012 Dec; 64(12):3963-71. PubMed ID: 22933061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intra-articular hyaluronate in experimental rabbit osteoarthritis can prevent changes in cartilage proteoglycan content.
    Hulmes DJ; Marsden ME; Strachan RK; Harvey RE; McInnes N; Gardner DL
    Osteoarthritis Cartilage; 2004 Mar; 12(3):232-8. PubMed ID: 14972340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Progress of research in osteoarthritis. Pharmacological effects of hyaluronan].
    Yasuda T
    Clin Calcium; 2009 Nov; 19(11):1644-52. PubMed ID: 19880998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyaluronan concentration and size distribution in human knee synovial fluid: variations with age and cartilage degeneration.
    Temple-Wong MM; Ren S; Quach P; Hansen BC; Chen AC; Hasegawa A; D'Lima DD; Koziol J; Masuda K; Lotz MK; Sah RL
    Arthritis Res Ther; 2016 Jan; 18():18. PubMed ID: 26792492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different effects of high molecular weight sodium hyaluronate and NSAID on the progression of the cartilage degeneration in rabbit OA model.
    Mihara M; Higo S; Uchiyama Y; Tanabe K; Saito K
    Osteoarthritis Cartilage; 2007 May; 15(5):543-9. PubMed ID: 17174116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the kinetics, metabolism and re-utilisation after intra-articular administration of hyaluronan to rabbits.
    Komatsu S; Iwata H; Nabeshima T
    Arzneimittelforschung; 1999 May; 49(5):427-33. PubMed ID: 10367105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A hyaluronic acid-salmon calcitonin conjugate for the local treatment of osteoarthritis: chondro-protective effect in a rabbit model of early OA.
    Mero A; Campisi M; Favero M; Barbera C; Secchieri C; Dayer JM; Goldring MB; Goldring SR; Pasut G
    J Control Release; 2014 Aug; 187():30-8. PubMed ID: 24837189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of sonication on simulated osteoarthritis. Part II: alleviation of osteoarthritis pathogenesis by 1 MHz ultrasound with simultaneous hyaluronate injection.
    Park SR; Park SH; Jang KW; Cho HS; Cui JH; An HJ; Choi MJ; Chung SI; Min BH
    Ultrasound Med Biol; 2005 Nov; 31(11):1559-66. PubMed ID: 16286033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alleviation of osteoarthritis by calycosin-7-O-beta-D-glucopyranoside (CG) isolated from Astragali radix (AR) in rabbit osteoarthritis (OA) model.
    Choi SI; Heo TR; Min BH; Cui JH; Choi BH; Park SR
    Osteoarthritis Cartilage; 2007 Sep; 15(9):1086-92. PubMed ID: 17408983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intra-articular injection of hyaluronan for the treatment of knee osteoarthritis].
    Fukuda K
    Clin Calcium; 2004 Jul; 14(7):103-7. PubMed ID: 15577085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Celecoxib has a positive effect on the overall metabolism of hyaluronan and proteoglycans in human osteoarthritic cartilage.
    El Hajjaji H; Marcelis A; Devogelaer JP; Manicourt DH
    J Rheumatol; 2003 Nov; 30(11):2444-51. PubMed ID: 14677191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-regulation of proteoglycan 4 in temporomandibular osteoarthritic synovial cells by hyaluronic acid.
    Guo H; Fang W; Li Y; Ke J; Deng M; Meng Q; Li J; Long X
    J Oral Pathol Med; 2015 Sep; 44(8):622-7. PubMed ID: 25366928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The serine protease inhibitor trappin-2 is present in cartilage and synovial fluid in osteoarthritis.
    Jaovisidha K; Etim A; Yamakawa K; Masuda I; Gohr CM; Wakim BT; Boonapatcharoen N; Ninomiya J; Rosenthal AK
    J Rheumatol; 2006 Feb; 33(2):318-25. PubMed ID: 16465664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Water-soluble C60 fullerene prevents degeneration of articular cartilage in osteoarthritis via down-regulation of chondrocyte catabolic activity and inhibition of cartilage degeneration during disease development.
    Yudoh K; Shishido K; Murayama H; Yano M; Matsubayashi K; Takada H; Nakamura H; Masuko K; Kato T; Nishioka K
    Arthritis Rheum; 2007 Oct; 56(10):3307-18. PubMed ID: 17907184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of sinomenine on synovial fluid and serum content of interleukin-1beta in rabbits with osteoarthritis].
    Yang HQ; Chen LR
    Zhong Xi Yi Jie He Xue Bao; 2008 Dec; 6(12):1275-9. PubMed ID: 19063843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cartilage boundary lubrication synergism is mediated by hyaluronan concentration and PRG4 concentration and structure.
    Ludwig TE; Hunter MM; Schmidt TA
    BMC Musculoskelet Disord; 2015 Dec; 16():386. PubMed ID: 26666513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of knee function and biochemical parameters of articular fluid and peripheral blood in gonarthrosis patients following intra-articular administration of hyaluronic acid.
    Ostałowska A; Nowak D; Święchowicz S; Birkner E; Brenk A; Kasperczyk S; Dobrakowski M; Machoń A
    Pol Orthop Traumatol; 2013 Aug; 78():173-81. PubMed ID: 23959433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Charge-based drug delivery to cartilage: Hydrophobic and not electrostatic interactions are the dominant cause of competitive binding of cationic carriers in synovial fluid.
    Vedadghavami A; He T; Zhang C; Amiji SM; Hakim B; Bajpayee AG
    Acta Biomater; 2022 Oct; 151():278-289. PubMed ID: 35963518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.